Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
affordable care act
life sciences
merck
biotech
clinical trials
deals
fda
johnson & johnson
nonalcoholic steatohepatitis
pembrolizumab
abbvie
abeona therapeutics
aducanumab
agios pharmaceuticals
What
bio
5
×
nash
5
×
roundup
5
×
drug
news
american
based
best
biogen’s
companies
continue
crash
debate
healthcare
industry
kind
people
pharmaceutical
policy
politicians
pressure
scalps
trump’s
u.s
aducanumab
alzheimer’s
amyloid
angst
approval
approved
bagged
billions
biogen
biopharmaceutical
brammer
convo
digital
disease
earlier
effects
Language
Current search:
bio
×
photo
×
roundup
×
nash
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More